- Home
- ALZN vs ADIL Comparison
ALZN vs ADIL Comparison
Compare ALZN & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- ADIL
- Stock Information
- Founded
- ALZN 2016
- ADIL 2010
- Country
- ALZN United States
- ADIL United States
- Employees
- ALZN N/A
- ADIL N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- ALZN Health Care
- ADIL Health Care
- Exchange
- ALZN Nasdaq
- ADIL Nasdaq
- Market Cap
- ALZN 7.5M
- ADIL 6.0M
- IPO Year
- ALZN 2021
- ADIL 2018
- Fundamental
- Price
- ALZN $2.32
- ADIL $0.35
- Analyst Decision
- ALZN Strong Buy
- ADIL Strong Buy
- Analyst Count
- ALZN 1
- ADIL 1
- Target Price
- ALZN $45.00
- ADIL $8.00
- AVG Volume (30 Days)
- ALZN 71.9K
- ADIL 591.1K
- Earning Date
- ALZN 09-10-2025
- ADIL 08-13-2025
- Dividend Yield
- ALZN N/A
- ADIL N/A
- EPS Growth
- ALZN N/A
- ADIL N/A
- EPS
- ALZN N/A
- ADIL N/A
- Revenue
- ALZN N/A
- ADIL N/A
- Revenue This Year
- ALZN N/A
- ADIL N/A
- Revenue Next Year
- ALZN N/A
- ADIL N/A
- P/E Ratio
- ALZN N/A
- ADIL N/A
- Revenue Growth
- ALZN N/A
- ADIL N/A
- 52 Week Low
- ALZN $2.06
- ADIL $0.22
- 52 Week High
- ALZN $22.23
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- ALZN 40.27
- ADIL 37.76
- Support Level
- ALZN $2.34
- ADIL $0.36
- Resistance Level
- ALZN $2.53
- ADIL $0.40
- Average True Range (ATR)
- ALZN 0.13
- ADIL 0.02
- MACD
- ALZN 0.02
- ADIL -0.00
- Stochastic Oscillator
- ALZN 29.03
- ADIL 18.77
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.